NIH Director’s Transformative Research Awards (R01 Clinical Trial Optional)
Funding Agency:
- National Institutes of Health
In order to support the most innovative and impactful research, the NIH recognizes the need to foster a diverse research workforce across the nation. Applications to this award program should reflect the full diversity of potential PD/PIs, applicant institutions, and research areas relevant to the broad mission of NIH. Researchers from underrepresented backgrounds (see NOT-OD-20-031), which includes individuals from underrepresented racial and ethnic groups, individuals with disabilities, individuals from disadvantaged backgrounds, and women are strongly encouraged to work with their institutions to develop applications for this Funding Opportunity Announcement. Since outstanding research is conducted at a broad spectrum of institutions, it benefits the national scientific enterprise to support exceptionally innovative and impactful science that represents this breadth. Therefore, this Funding Opportunity Announcement encourages applications from the full range of eligible institutions, including minority serving institutions . Applications , from all domestic geographic locations, and from institutions that are less research intensive also also encouraged. Applications are also welcome in all research areas broadly relevant to the mission of NIH. These areas include, but are not limited to, behavioral, medical, natural, social, applied, and formal sciences. Research may be basic, translational, or clinical. The primary requirements are that the research be highly innovative and have the potential for unusually broad impact.
Towards the objective of funding the best possible science, the Office of Strategic Coordination and the Center for Scientific Review are piloting a process for initial peer review of applications received in response to this FOA in which the identity of the investigators and institutions are withheld until the last phase of review. Instructions for anonymizing components of the application are given in Section IV and must be carefully followed. If anonymization instructions are not followed, the application will be administratively withdrawn. A description of the review process is given in Section V.
Prospective applicants are invited to a pre-application webinar on June 23, 2022, from 1:00-2:30 PM EDT. Questions for the webinar should be submitted ahead of time to Transformative_Awards@mail.nih.gov by 11:59 PM local time on June 20, 2022.
Application budgets are not limited but must be commensurate with the scope of the proposed research.
September 01, 2022
Ravi Basavappa, Ph.D., Office of the Director (OD), Telephone: 301-435-7204
Email: Transformative_Awards@mail.nih.gov